International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Privacy Statement
International Journal of Pharmaceutical and Phytopharmacological Research is committed to protect your privacy and developing technology that gives you the most powerful and safe online experience. This Statement of Privacy applies to this Web site and governs data collection and usage. By using our Web site, you consent to the data practices described in this statement.
Collection of your Personal Information
Our Web site collects personally identifiable information, such as your e-mail address, name, home or work address, or telephone number. It also collects anonymous demographic information, which is not unique to you, such as your ZIP code, age, gender, preferences, interests, and favorites.
There is also information about your computer hardware and software that is automatically collected. This information can include: your IP address, browser type, domain names, access times, and referring Web site addresses. This information is used for the operation of the service, to maintain the quality of the service, and to provide general statistics regarding the use of our Web site.
Please keep in mind that if you directly disclose personally identifiable information or personally sensitive data, this information may be collected and used by others. Note: Our Web site does not read any of your private online communications.
We encourage you to review the privacy statements of Web sites you choose to link to so that you can understand how those Web sites collect, use and share your information. Our Web site is not responsible for the privacy statements or other content on Web sites outside.
Use of your Personal Information
Our Web site collects and uses your personal information to operate and deliver the services you have requested. It also uses your personally identifiable information to inform you of other products or services available. We may also contact you via surveys to conduct research about your opinion of current services or of potential new services that may be offered.
We do not sell, rent or lease our customer lists to third parties. We may, from time to time, contact you on behalf of external business partners about a particular offering that may be of interest to you. In those cases, your unique personally identifiable information (e-mail, name, address, telephone number) is not transferred to the third party. In addition, we may share data with trusted partners to help us perform statistical analysis, send you emails or postal mail, provide customer support, or arrange for deliveries. All such third parties are prohibited from using your personal information.
Our Web site does not use or disclose sensitive personal information, such as race, religion, or political affiliations, without your explicit consent.
Our Web site keeps track of the Web sites and pages our customers visit within our main Web site, to determine what services are the most popular. This data is used to deliver customized content and advertising within our Web site to customers whose behavior indicate that they are interested in a particular subject area.
Our Web site will disclose your personal information, without notice, only if required to do so by law or in the good faith belief that such action is necessary to: (a) conform to the edicts of the law or comply with legal process served on the site; (b) protect and defend the rights or property of the journal; and, (c) act under exigent circumstances to protect the personal safety of users of the journal, or the public.
Use of Cookies
Our Web site use “cookies” to help you personalize your online experience. A cookie is a text file that is placed on your hard disk by a Web page server. Cookies cannot be used to run programs or deliver viruses to your computer. Cookies are uniquely assigned to you, and can only be read by a web server in the domain that issued the cookie to you.
One of the primary purposes of cookies is to provide a convenience feature to save you time. The purpose of a cookie is to tell the Web server that you have returned to a specific page. For example, if you personalize our pages, or register with site or services, a cookie helps the journal to recall your specific information on subsequent visits. This simplifies the process of recording your personal information, such as billing addresses, shipping addresses, and so on. When you return to the same Web site, the information you previously provided can be retrieved, so you can easily use features that you customized.
You can accept or decline cookies. Most Web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer. If you choose to decline cookies, you may not be able to fully experience the interactive features of services or Web sites you visit.
Security of your Personal Information
Our Journal secures your personal information from unauthorized access, use, or disclosure. The Web site secures the personally identifiable information you provide on computer servers in a controlled, secure environment, protected from unauthorized access, use, or disclosure. When personal information (such as a credit card number) is transmitted to other Web sites, it is protected through the use of encryption, such as the Secure Socket Layer (SSL) protocol.
Changes to this Statement
We will occasionally update this Statement of Privacy to reflect company and customer feedback. We encourage you to periodically review this Statement to be informed of how our journal is protecting your information.
Contact Information
We welcome your comments regarding this Statement of Privacy. If you believe that the journal has not adhered to this Statement, please contact us. We will use commercially reasonable efforts to promptly determine and remedy the problem.
Peer Review
International Journal of Pharmaceutical and Phytopharmacological Research follows a double-blind peer review process; identities of neither authors nor peer reviewers are disclosed. Authors should ensure that papers conform to the scientific and style instructions of the journal. If authors don't follow the simple guidelines, the submission will be returned for an additional revision.
International Journal of Pharmaceutical and Phytopharmacological Research only considers manuscripts that have not been submitted to other Journals simultaneously; they have not been published already, nor are they under consideration for publication or in press elsewhere. International Journal of Pharmaceutical and Phytopharmacological Research has a completely digital submission, review, and production process. The editor for suitability will initially assess all contributions to the journal. Papers deemed suitable are then typically sent to a minimum of three independent expert reviewers based on many factors, including expertise, reputation, specific recommendations, conflict of interest, and previous performance to assess the paper's scientific quality. Potential peer reviewers should inform the Editor of any possible conflicts of interest before accepting an invitation to review a manuscript. Communications between Editors and peer reviewers contain confidential information that should not be shared with third parties.
The Peer Review Process
1. The Editor-in-Chief’s review
Immediately after submission, the Editor-in-Chief pre-checks the manuscript to comply with the journal's purpose, scope and adhere to ethical research and writing standards.
2. The Editorial Board Review
The editor-in-chief determines the two internal reviewers from the members of the Editorial Board according to their field of expertise. Internal reviewers evaluate the manuscript in terms of its subject, method, and results and decide whether it should be included in the external review process for detailed evaluation. Reviewer identity is not made visible to the author, author identity is not made visible to the reviewer, reviewer, and author identity is visible to (decision-making) editor.
3. The Peer Review
Two external reviewers take charge at this stage.
The Section Editor chooses two external reviewers who specialize in the research topic of the manuscript. In cases where a reviewer with expertise in the manuscript's subject cannot be identified, scholars holding a doctorate in the relevant field are selected. The reviewers thoroughly assess the article, considering its subject matter, methodology, and findings, providing their recommendations on whether the paper should be published. If both reviewers offer positive feedback, the manuscript is approved for publication under the decision of the Editor-in-Chief. In the event of a negative opinion from one of the two reviewers, the manuscript undergoes review by a third expert. Publication is possible with the favorable decisions of at least two reviewers. The identities of reviewers remain undisclosed to the author, and the author's identity is likewise concealed from the reviewers. The editor responsible for decision-making has access to the identities of both reviewers and authors.
Please see the following chart for more details of the evaluation of the manuscript:
Editorial Decision and Revision
All the articles, reviews and communications published in our journal go through the double blind peer-review process and receive at least two reviews. The decision will be one of the following:
All reviewer comments should be responded to in a point-by-point fashion. Where the authors disagree with a reviewer, they must provide a clear response.
Duration of the review process
The duration of the review process relies on the responsiveness of the referees, typically spanning around 2-3 months. In instances where referee reports conflict or face unnecessary delays, an additional expert opinion will be sought. In uncommon scenarios where securing a second referee is exceptionally challenging or when one referee's report thoroughly convinces the Editor, decisions on acceptance, rejection, or the need for revision are based solely on one referee's evaluation. The Editor conveys the decision to the author, along with recommendations from referees, often including direct comments. Revised manuscripts may be re-evaluated by the initial referees, who may request further revisions. A conclusive decision on manuscript acceptance or rejection, along with referees' recommendations and potential verbatim comments, is communicated to the author. The Editor's decision holds ultimate authority, as referees offer guidance while the Editor bears responsibility for the final acceptance or rejection of the article.
Complaints Policy
We aim to respond to and resolve all complaints quickly and constructively. The procedures to investigate and resolve complaints followed by International Journal of Pharmaceutical and Phytopharmacological Research aim to be fair and balanced for those making complaints and for those being complained about.
In the event of disagreement with editorial decisions, authors retain the right to appeal. Authors seeking to appeal should contact the Editor-in-Chief directly. The Editor-in-Chief will thoroughly review the manuscript, along with editorial and peer reviewers' feedback, and render a final decision on acceptance or rejection. If necessary, the manuscript may be reassigned to a new handling editor for further evaluation. The Editor-in-Chief's decision in these matters is conclusive.
Regarding complaints concerning policies, procedures, editorial content, or the conduct of editorial staff, the complaint process is straightforward. Complaints can be submitted via email, ideally directed to the relevant contact person for the issue at hand. If contacting the designated person is not feasible, complaints may be sent to [email protected]. All complaints will receive acknowledgment within six working days.
In matters pertaining to policies, procedures, editorial content, or editorial staff actions, the Editor-in-Chief's decision is considered final.
Efforts will be made to resolve complaints promptly. However, some delays may occur if responses from external parties are required. Complainants will receive updates on the progress of their complaints every two weeks until resolution is achieved.
Conflict of interest
Authors are required to include a 'Competing Interests' statement as part of their submission. The presence of a competing interest does not automatically result in non-publication, but it ensures transparency for both reviewers and readers. In cases where no competing interests exist, a standard disclosure is made: 'No competing interests were disclosed.'
Competing interests can manifest in various forms, encompassing both financial and non-financial aspects. Instances of competing interests include, but are not restricted to:
Authors affiliated with pharmaceutical companies or other commercial entities sponsoring clinical trials, field studies, or other research endeavors should explicitly declare these as competing interests during the submission process. Additionally, the nature of each author's association with such organizations should be detailed in the 'Competing Interests' section.
The Editor is responsible for the final decision regarding the acceptance or rejection of articles. Editors will consider the peer-reviewed reports when making a decision but are not bound by the opinions or recommendations.
Editors are not involved in decisions about papers that they have written themselves. Peer-reviewed articles support and exemplify the scientific method. Therefore, it is important to agree upon standards of expected ethical behavior for all parties involved in publishing: the author, the journal editor, the peer reviewer, the publisher, and the society. A concern raised by a single peer reviewer or the editor may result in the manuscript being rejected. Peer review's primary purpose is to provide the Editor with the information needed to reach a fair, evidence-based decision. Authors receive peer review reports with the editorial decision on their manuscript. Review reports help authors revise their paper such that it may be accepted for publication. Reports accompanied by a recommendation to reject the paper explain the major weaknesses of the research; this will help the authors prepare their manuscript for submission to a different journal. As per these guidelines, failure to adhere to the above conditions will result in the editor-in-chief and publisher taking an appropriate correction. In extreme cases, offending authors may be banned from submitting to the journal in the future, or the issue will be reported to their institution’s ethics committee.
Our journal is guided by COPE guidelines, ensuring integrity and ethical standards in our editorial processes. However, we also prioritize our existing policies and principles, which encompass a commitment to academic rigor, fairness, and transparency. While we value the guidance provided by COPE, our independent decisions are rooted in a comprehensive framework that considers the unique aspects of our publication, the scholarly community we serve, and the evolving landscape of academic publishing. This approach enables us to uphold the highest standards of scholarly integrity while maintaining the autonomy necessary to adapt to emerging challenges and opportunities in the field.
